Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.

Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.

老虎证券老虎证券2026/07/06 12:51
Show original
This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI-driven selloff boosts safe-haven demand; yen and Swiss franc lead major currencies as the US dollar declines

On Friday, as concerns grew over the sustainability of the AI frenzy, both the Japanese yen and the Swiss franc rose 0.6% against the US dollar, with the yen set to record its largest single-day gain in nearly a month. Analysts noted that when the market shifts toward risk aversion, unwinding of yen carry trades tends to strengthen the yen, while the Swiss franc has long served as a balance sheet hedging tool at the institutional level.

华尔街见闻•2026/11/20 20:01
AI-driven selloff boosts safe-haven demand; yen and Swiss franc lead major currencies as the US dollar declines